Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT01835730 · COMPLETED
Trial details
- NCT number
- NCT01835730
- Sponsor
- PhaseBio Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.